Yoga for Breast Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01985945
First received: November 11, 2013
Last updated: January 22, 2016
Last verified: January 2016
  Purpose
The purpose of this study is to examine the use of Eischens yoga for 8 weeks in one cohort of 20 women with stage I and II breast cancer receiving radiation therapy treatment, while a second cohort of the same type of and number of patients who, instead of yoga will receive standard supportive therapy, Questionnaire measuring cancer-related quality of life (FACT-G instrument) and fatigue (Brief Fatique Inventory) will be given to patients at several points.

Condition Intervention
Women With Stage I or II Breast Cancer Undergoing Active Radiation Therapy
Other: Yoga

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: A Randomized Study of the Effect of Yoga in Patients With Breast Cancer Receiving Radiation Therapy

Resource links provided by NLM:


Further study details as provided by Abramson Cancer Center of the University of Pennsylvania:

Primary Outcome Measures:
  • Number of Adverse Events [ Time Frame: One Year ] [ Designated as safety issue: Yes ]

Enrollment: 70
Study Start Date: March 2013
Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Yoga Other: Yoga
No Intervention: Without Yoga

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Stage I and II breast cancer patients undergoing active radiation therapy
  • Above the age of 18
  • Must sign informed consent form
  • Must speak English
  • Only women are eligible

Exclusion Criteria:

  • Patients with medical restrictions that may interfere with yoga participation per their physicians' decision
  • Those who have smoked in the last 6 months because smoking can interfere with the breathing and relaxation techniques of yoga.
  • Those who have regularly taken yoga in the last 6 months, because they would not come to the intervention with the same baseline as other participants.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01985945

Locations
United States, Pennsylvania
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
Abramson Cancer Center of the University of Pennsylvania
Investigators
Principal Investigator: Lilie Lin, MD Abramson Cancer Center of the University of Pennsylvania
  More Information

Responsible Party: Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier: NCT01985945     History of Changes
Other Study ID Numbers: UPCC 08113 
Study First Received: November 11, 2013
Last Updated: January 22, 2016
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Breast Neoplasms
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases

ClinicalTrials.gov processed this record on April 27, 2016